Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot 3-week randomized open-label comparison of Seroquel Prolong vs oral Risperdal in acute schizophrenia inpatients
2007-005773-63Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine, risperidone in schizophrenia, sponsored by AstraZeneca. Started Feb 2008; status: completed.
02
Drugs
quetiapinerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-005773-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005773-63.